| 1 |
30664934 | A novel framework to compare the effectiveness of β-lactamase inhibitors against extended-spectrum β-lactamase-producing Enterobacteriaceae. | 2019 Sep |
1 |
| 2 |
29796032 | Prevalence and Antimicrobial Susceptibility Patterns of ESBL, AmpC and Carbapenemase-producing Enterobactericeae Isolated from Hospitalized Patients in Azerbaijan, Iran. | 2018 Winter |
1 |
| 3 |
27931793 | In vitro pharmacodynamic evaluation of ceftolozane/tazobactam against β-lactamase-producing Escherichia coli in a hollow-fibre infection model. | 2017 Jan |
1 |
| 4 |
24041895 | Pharmacological basis of β-lactamase inhibitor therapeutics: tazobactam in combination with Ceftolozane. | 2013 Dec |
3 |
| 5 |
20067122 | [Post antibiotic, post beta-lactamase inhibitor and post antibiotic sub-MIC effect of ceftriaxone/tazobactam on beta-lactamase-producing Escherichia coli in vitro]. | 2009 Nov |
3 |
| 6 |
8257123 | Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. | 1993 Oct |
1 |
| 7 |
8392995 | Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors. | 1993 May |
1 |
| 8 |
1685175 | Antimicrobial activities of piperacillin alone and in combination with tazobactam against beta-lactamase-producing bacteria. | 1991 Oct |
4 |